Clinical trials
Observational Obesity trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Unknown status | 13 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 3 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Aarhus | 13 |
| Hvidovre University Hospital | 11 |
| University of Copenhagen | 6 |
| Bispebjerg Hospital | 5 |
| Novo Nordisk A/S | 5 |
| Henrik Gudbergsen | 4 |
| University Hospital, Gentofte, Copenhagen | 4 |
| Odense University Hospital | 3 |
| Claus Bogh Juhl | 2 |
| Holbaek Sygehus | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 67 |
| Overweight | 17 |
| Diabetes Mellitus, Type 2 | 16 |
| Insulin Resistance | 9 |
| Cardiovascular Diseases | 5 |
| Inflammation | 5 |
| Osteoarthritis | 5 |
| Diabetes Mellitus | 4 |
| Birth Weight | 2 |
| Body Weight | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.